Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
Status:
Terminated
Trial end date:
2020-06-08
Target enrollment:
Participant gender:
Summary
Double blinded randomized clinical trial designed to evaluate the efficacy and safety of
hydroxychloroquine combined with azithromycin compared to hydroxychloroquine monotherapy in
patients hospitalized with confirmed COVID-19 pneumonia.